Cepheid Smart GBS Test for Group B Streptococcus, Run on the SmartCycler(R) System, Receives 510(k) FDA Clearance (PR Newswire via Yahoo! Finance)
Cepheid , a broad-based molecular diagnostics company, today announced it received 510 clearance from the U.S. Food & Drug Administration to market its Smart GBS test for Group B Streptococcus on its SmartCycler platform.

FDA Approves VELCADE(R) (Bortezomib) For Injection For Aggressive Form Of Non-Hodgkin's Lymphoma (Medical News Today)
Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval of VELCADE for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. [click link for full article]

Data presented to FDA panel show Taxus (Antara News)
(Full text of a statement. Contact details below.)